[
    [
        {
            "time": "2021-12",
            "original_text": "医药行业2021年12月投资月报：业绩和政策真空期 医药板块有望持续反弹",
            "features": {
                "keywords": [
                    "医药",
                    "业绩",
                    "政策",
                    "真空期",
                    "反弹"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "医药行业2021年12月投资月报：业绩和政策真空期 医药板块有望持续反弹",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "recent",
            "original_text": "北向资金连续4日净买入累计加仓超150亿，大幅抢筹券商、银行股",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买入",
                    "加仓",
                    "券商",
                    "银行股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金连续4日净买入累计加仓超150亿，大幅抢筹券商、银行股",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "recent",
            "original_text": "医药行业一周观察：医保谈判落地 国产创新药收获颇丰",
            "features": {
                "keywords": [
                    "医药",
                    "医保谈判",
                    "国产创新药",
                    "收获颇丰"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "医药行业一周观察：医保谈判落地 国产创新药收获颇丰",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021",
            "original_text": "2021年基金，买了个“寂寞”",
            "features": {
                "keywords": [
                    "基金",
                    "寂寞"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2021年基金，买了个“寂寞”",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2022",
            "original_text": "粤开策略深度 | 医药生物行业2022年展望：价值重鸣，创新为锋",
            "features": {
                "keywords": [
                    "医药生物",
                    "价值重鸣",
                    "创新为锋"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "粤开策略深度 | 医药生物行业2022年展望：价值重鸣，创新为锋",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "recent",
            "original_text": "天风证券给予迈瑞医疗买入评级，医疗新基建引领需求，“三瑞”系统构建智慧医疗生态圈，目标价格为426元",
            "features": {
                "keywords": [
                    "天风证券",
                    "迈瑞医疗",
                    "买入评级",
                    "医疗新基建",
                    "三瑞系统",
                    "智慧医疗"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "天风证券给予迈瑞医疗买入评级，医疗新基建引领需求，“三瑞”系统构建智慧医疗生态圈，目标价格为426元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "recent",
            "original_text": "天风证券：维持迈瑞医疗(300760.SZ)“买入”评级 目标价上调至426元",
            "features": {
                "keywords": [
                    "天风证券",
                    "迈瑞医疗",
                    "买入评级",
                    "目标价上调"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "天风证券：维持迈瑞医疗(300760.SZ)“买入”评级 目标价上调至426元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "recent",
            "original_text": "瑞影云++上线2年，迈瑞智慧医疗探索结硕果",
            "features": {
                "keywords": [
                    "瑞影云++",
                    "迈瑞",
                    "智慧医疗",
                    "硕果"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "瑞影云++上线2年，迈瑞智慧医疗探索结硕果",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "recent",
            "original_text": "医药生物行业：医保谈判落地 释放积极信号",
            "features": {
                "keywords": [
                    "医药生物",
                    "医保谈判",
                    "积极信号"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "医药生物行业：医保谈判落地 释放积极信号",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]